CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-01 | Erlander Mark Chief Scientific Officer | Exercise or conversion | +1,250 | 4,419 | ||
| 2019-04-01 | Erlander Mark Chief Scientific Officer | Shares withheld for taxes | −459 | 3,960 | ||
| 2019-04-01 | Erlander Mark Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −1,250 | 4,271 | ||
| 2019-01-02 | Erlander Mark Chief Scientific Officer | Exercise or conversion | +1,563 | 19,708 | ||
| 2019-01-02 | Erlander Mark Chief Scientific Officer | Shares withheld for taxes | −698 | 19,010 | ||
| 2019-01-02 | Erlander Mark Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −1,563 | 33,125 | ||
| 2019-01-01 | Erlander Mark Chief Scientific Officer | Exercise or conversion | +7,500 | 21,180 | ||
| 2019-01-01 | Erlander Mark Chief Scientific Officer | Shares withheld for taxes | −3,035 | 18,145 | ||
| 2019-01-01 | Erlander Mark Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −7,500 | 34,688 | ||
| 2018-10-01 | Erlander Mark Chief Scientific Officer | Exercise or conversion | +7,500 | 16,411 | ||
| 2018-10-01 | Erlander Mark Chief Scientific Officer | Shares withheld for taxes | −2,731 | 13,680 | ||
| 2018-10-01 | Erlander Mark Chief Scientific Officer | Exercise or conversion · Restricted Stock Units | −7,500 | 42,188 | ||
| 2018-07-24 | Erlander Mark Chief Scientific Officer | Grant or award · Restricted Stock Units | +45,000 | 49,688 | ||
| 2018-06-20 | Markin Rodney S Director | Purchase | +41,200 | $0.85 | $35K | 43,085 |
| 2018-06-20 | Markin Rodney S Director | Purchase | +41,200 | $0.85 | $35K | 63,810 |
| 2018-06-08 | Tennant Stanley Director | Purchase | +10,000 | $0.80 | $8K | 28,839 |
| 2018-06-08 | BRANCACCIO JOHN P Director | Purchase | +10,000 | $0.80 | $8K | 13,598 |
| 2018-06-08 | BRANCACCIO JOHN P Director | Purchase | +10,000 | $0.80 | $8K | 53,167 |
| 2018-06-08 | Tennant Stanley Director | Purchase | +10,000 | $0.80 | $8K | 236,061 |
| 2018-01-30 | Erlander Mark Chief Scientific Officer | Exercise or conversion | +90,000 | 147,297 |
Page 10 of 15 · 299 trades